Typical daily range: 50100 mg once daily subcutaneously, started low and raised gradually to tolerance over an 812 week course
Eye conditions: Is red light effective and safe for treating eye conditions , such as macular degeneration
What insurance typically covers FDA-approved peptides for approved indications: Semaglutide (Ozempic) for type 2 diabetes: Often covered Semaglutide (Wegovy) for obesity: Sometimes covered with restrictions Tirzepatide (Mounjaro) for type 2 diabetes: Often covered Tirzepatide (Zepbound) for obesity: Limited coverage What coverage looks like: Prior authorization typically required Documentation of failed dietary interventions BMI thresholds for weight loss indications Co-pays still substantial ($100-500 monthly) What insurance doesn't cover The vast majority of peptide therapy falls outside insurance coverage: Compounded peptides (BPC-157, TB-500, most growth hormone peptides) Anti-aging applications even for FDA-approved drugs Performance enhancement uses Off-label applications These costs are entirely out-of-pocket for most patients
But sermorelin is also one of those peptides that occasionally appears as an oral medication, similar to how you can now find GLP-1 receptor agonists (e.g., semaglutide, the generic form of Ozempic) in pill form
Most peptide therapies address symptoms of aging, but Epithalon potentially addresses one of its root causes at the cellular level
